CCL INDUSTRIES INC - CL B (CCL-B.CA) Fundamental Analysis & Valuation

TSX:CCL-B • CA1249003098

Current stock price

86.36 CAD
+0.88 (+1.03%)
Last:

This CCL-B.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CCL-B.CA Profitability Analysis

1.1 Basic Checks

  • CCL-B had positive earnings in the past year.
  • CCL-B had a positive operating cash flow in the past year.
  • Each year in the past 5 years CCL-B has been profitable.
  • Each year in the past 5 years CCL-B had a positive operating cash flow.
CCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • CCL-B's Return On Assets of 7.94% is amongst the best of the industry. CCL-B outperforms 88.89% of its industry peers.
  • Looking at the Return On Equity, with a value of 14.23%, CCL-B belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
  • The Return On Invested Capital of CCL-B (11.25%) is better than 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CCL-B is in line with the industry average of 8.82%.
  • The last Return On Invested Capital (11.25%) for CCL-B is above the 3 year average (10.12%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.94%
ROE 14.23%
ROIC 11.25%
ROA(3y)7.48%
ROA(5y)7.5%
ROE(3y)13.89%
ROE(5y)14.45%
ROIC(3y)10.12%
ROIC(5y)9.94%
CCL-B.CA Yearly ROA, ROE, ROICCCL-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • CCL-B has a Profit Margin of 10.47%. This is in the better half of the industry: CCL-B outperforms 77.78% of its industry peers.
  • In the last couple of years the Profit Margin of CCL-B has remained more or less at the same level.
  • The Operating Margin of CCL-B (15.10%) is better than 88.89% of its industry peers.
  • In the last couple of years the Operating Margin of CCL-B has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 29.96%, CCL-B is in line with its industry, outperforming 55.56% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CCL-B has remained more or less at the same level.
Industry RankSector Rank
OM 15.1%
PM (TTM) 10.47%
GM 29.96%
OM growth 3Y3.77%
OM growth 5Y0.38%
PM growth 3Y2.38%
PM growth 5Y0.71%
GM growth 3Y3.69%
GM growth 5Y0.9%
CCL-B.CA Yearly Profit, Operating, Gross MarginsCCL-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CCL-B.CA Health Analysis

2.1 Basic Checks

  • CCL-B has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, CCL-B has less shares outstanding
  • CCL-B has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CCL-B has an improved debt to assets ratio.
CCL-B.CA Yearly Shares OutstandingCCL-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
CCL-B.CA Yearly Total Debt VS Total AssetsCCL-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 3.91 indicates that CCL-B is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.91, CCL-B belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
  • CCL-B has a debt to FCF ratio of 2.62. This is a good value and a sign of high solvency as CCL-B would need 2.62 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.62, CCL-B belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
  • CCL-B has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of CCL-B (0.27) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 2.62
Altman-Z 3.91
ROIC/WACC1.53
WACC7.34%
CCL-B.CA Yearly LT Debt VS Equity VS FCFCCL-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • CCL-B has a Current Ratio of 1.42. This is a normal value and indicates that CCL-B is financially healthy and should not expect problems in meeting its short term obligations.
  • CCL-B has a Current ratio of 1.42. This is in the lower half of the industry: CCL-B underperforms 66.67% of its industry peers.
  • A Quick Ratio of 1.07 indicates that CCL-B should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.07, CCL-B is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • The current and quick ratio evaluation for CCL-B is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.07
CCL-B.CA Yearly Current Assets VS Current LiabilitesCCL-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CCL-B.CA Growth Analysis

3.1 Past

  • The earnings per share for CCL-B have decreased by -2.77% in the last year.
  • Measured over the past years, CCL-B shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.28% on average per year.
  • Looking at the last year, CCL-B shows a small growth in Revenue. The Revenue has grown by 5.78% in the last year.
  • Measured over the past years, CCL-B shows a small growth in Revenue. The Revenue has been growing by 7.89% on average per year.
EPS 1Y (TTM)-2.77%
EPS 3Y8.99%
EPS 5Y8.28%
EPS Q2Q%-1.98%
Revenue 1Y (TTM)5.78%
Revenue growth 3Y6.29%
Revenue growth 5Y7.89%
Sales Q2Q%3.51%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.96% on average over the next years. This is quite good.
  • CCL-B is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.16% yearly.
EPS Next Y10.48%
EPS Next 2Y8.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.9%
Revenue Next 2Y4.16%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CCL-B.CA Yearly Revenue VS EstimatesCCL-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
CCL-B.CA Yearly EPS VS EstimatesCCL-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

3

4. CCL-B.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.90 indicates a rather expensive valuation of CCL-B.
  • Compared to the rest of the industry, the Price/Earnings ratio of CCL-B indicates a slightly more expensive valuation: CCL-B is more expensive than 66.67% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.70, CCL-B is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 17.11, the valuation of CCL-B can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CCL-B is on the same level as its industry peers.
  • CCL-B's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 18.9
Fwd PE 17.11
CCL-B.CA Price Earnings VS Forward Price EarningsCCL-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CCL-B is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as CCL-B.
Industry RankSector Rank
P/FCF 17.33
EV/EBITDA 9.91
CCL-B.CA Per share dataCCL-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CCL-B does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of CCL-B may justify a higher PE ratio.
PEG (NY)1.8
PEG (5Y)2.28
EPS Next 2Y8.96%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CCL-B.CA Dividend Analysis

5.1 Amount

  • CCL-B has a Yearly Dividend Yield of 1.68%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.47, CCL-B has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, CCL-B has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.68%

5.2 History

  • On average, the dividend of CCL-B grows each year by 12.18%, which is quite nice.
  • CCL-B has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CCL-B has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)12.18%
Div Incr Years23
Div Non Decr Years34
CCL-B.CA Yearly Dividends per shareCCL-B.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • CCL-B pays out 27.88% of its income as dividend. This is a sustainable payout ratio.
  • CCL-B's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP27.88%
EPS Next 2Y8.96%
EPS Next 3YN/A
CCL-B.CA Yearly Income VS Free CF VS DividendCCL-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
CCL-B.CA Dividend Payout.CCL-B.CA Dividend Payout, showing the Payout Ratio.CCL-B.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CCL-B.CA Fundamentals: All Metrics, Ratios and Statistics

CCL INDUSTRIES INC - CL B

TSX:CCL-B (3/13/2026, 7:00:00 PM)

86.36

+0.88 (+1.03%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners38.7%
Inst Owner ChangeN/A
Ins Owners1.91%
Ins Owner ChangeN/A
Market Cap14.96B
Revenue(TTM)7.66B
Net Income(TTM)802.40M
Analysts82.11
Price Target100.75 (16.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.68%
Yearly Dividend1.28
Dividend Growth(5Y)12.18%
DP27.88%
Div Incr Years23
Div Non Decr Years34
Ex-Date03-17
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.08%
Min EPS beat(2)-12.42%
Max EPS beat(2)0.26%
EPS beat(4)3
Avg EPS beat(4)-1.45%
Min EPS beat(4)-12.42%
Max EPS beat(4)4.21%
EPS beat(8)5
Avg EPS beat(8)4.61%
EPS beat(12)6
Avg EPS beat(12)1.41%
EPS beat(16)8
Avg EPS beat(16)1.3%
Revenue beat(2)0
Avg Revenue beat(2)-1.77%
Min Revenue beat(2)-3.09%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.56%
Min Revenue beat(4)-3.09%
Max Revenue beat(4)-0.46%
Revenue beat(8)1
Avg Revenue beat(8)-1.24%
Revenue beat(12)1
Avg Revenue beat(12)-1.79%
Revenue beat(16)3
Avg Revenue beat(16)-1.61%
PT rev (1m)0.79%
PT rev (3m)1.62%
EPS NQ rev (1m)-2.62%
EPS NQ rev (3m)-2.62%
EPS NY rev (1m)-0.61%
EPS NY rev (3m)-0.11%
Revenue NQ rev (1m)-1.1%
Revenue NQ rev (3m)-0.2%
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)0.43%
Valuation
Industry RankSector Rank
PE 18.9
Fwd PE 17.11
P/S 1.95
P/FCF 17.33
P/OCF 11.47
P/B 2.65
P/tB 7.47
EV/EBITDA 9.91
EPS(TTM)4.57
EY5.29%
EPS(NY)5.05
Fwd EY5.85%
FCF(TTM)4.98
FCFY5.77%
OCF(TTM)7.53
OCFY8.72%
SpS44.24
BVpS32.56
TBVpS11.56
PEG (NY)1.8
PEG (5Y)2.28
Graham Number57.86
Profitability
Industry RankSector Rank
ROA 7.94%
ROE 14.23%
ROCE 14.79%
ROIC 11.25%
ROICexc 12.9%
ROICexgc 27.61%
OM 15.1%
PM (TTM) 10.47%
GM 29.96%
FCFM 11.26%
ROA(3y)7.48%
ROA(5y)7.5%
ROE(3y)13.89%
ROE(5y)14.45%
ROIC(3y)10.12%
ROIC(5y)9.94%
ROICexc(3y)11.38%
ROICexc(5y)11.15%
ROICexgc(3y)23.06%
ROICexgc(5y)22.82%
ROCE(3y)13.31%
ROCE(5y)13.07%
ROICexgc growth 3Y9.39%
ROICexgc growth 5Y2.67%
ROICexc growth 3Y7.52%
ROICexc growth 5Y3.22%
OM growth 3Y3.77%
OM growth 5Y0.38%
PM growth 3Y2.38%
PM growth 5Y0.71%
GM growth 3Y3.69%
GM growth 5Y0.9%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 2.62
Debt/EBITDA 0.94
Cap/Depr 94.84%
Cap/Sales 5.76%
Interest Coverage 21.67
Cash Conversion 80.39%
Profit Quality 107.58%
Current Ratio 1.42
Quick Ratio 1.07
Altman-Z 3.91
F-Score7
WACC7.34%
ROIC/WACC1.53
Cap/Depr(3y)105.38%
Cap/Depr(5y)106.63%
Cap/Sales(3y)6.36%
Cap/Sales(5y)6.35%
Profit Quality(3y)93.71%
Profit Quality(5y)90.94%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.77%
EPS 3Y8.99%
EPS 5Y8.28%
EPS Q2Q%-1.98%
EPS Next Y10.48%
EPS Next 2Y8.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.78%
Revenue growth 3Y6.29%
Revenue growth 5Y7.89%
Sales Q2Q%3.51%
Revenue Next Year3.9%
Revenue Next 2Y4.16%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.7%
EBIT growth 3Y10.29%
EBIT growth 5Y8.3%
EBIT Next Year36.86%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y43.41%
FCF growth 3Y16.52%
FCF growth 5Y7.54%
OCF growth 1Y22.61%
OCF growth 3Y9.53%
OCF growth 5Y8.12%

CCL INDUSTRIES INC - CL B / CCL-B.CA Fundamental Analysis FAQ

What is the fundamental rating for CCL-B stock?

ChartMill assigns a fundamental rating of 6 / 10 to CCL-B.CA.


What is the valuation status for CCL-B stock?

ChartMill assigns a valuation rating of 3 / 10 to CCL INDUSTRIES INC - CL B (CCL-B.CA). This can be considered as Overvalued.


How profitable is CCL INDUSTRIES INC - CL B (CCL-B.CA) stock?

CCL INDUSTRIES INC - CL B (CCL-B.CA) has a profitability rating of 8 / 10.


What are the PE and PB ratios of CCL INDUSTRIES INC - CL B (CCL-B.CA) stock?

The Price/Earnings (PE) ratio for CCL INDUSTRIES INC - CL B (CCL-B.CA) is 18.9 and the Price/Book (PB) ratio is 2.65.


What is the earnings growth outlook for CCL INDUSTRIES INC - CL B?

The Earnings per Share (EPS) of CCL INDUSTRIES INC - CL B (CCL-B.CA) is expected to grow by 10.48% in the next year.